U.S. markets closed

Agios Pharmaceuticals, Inc. (AGIO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
22.97+0.42 (+1.86%)
At close: 04:00PM EDT
22.97 0.00 (0.00%)
After hours: 04:08PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Outside Bar (Bearish)

Outside Bar (Bearish)

Previous Close22.55
Bid22.89 x 1200
Ask24.52 x 900
Day's Range22.62 - 23.38
52 Week Range16.75 - 34.76
Avg. Volume541,883
Market Cap1.27B
Beta (5Y Monthly)0.96
PE Ratio (TTM)N/A
EPS (TTM)-4.20
Earnings DateMay 03, 2023 - May 08, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est37.80
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for AGIO

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Agios Pharmaceuticals, Inc.
    JAZZ: Raising target price to $157.00JAZZ PHARMACEUTICALS PLC has an Investment Rating of BUY; a target price of $157.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.
    Fair Value
    Economic Moat
    3 days agoArgus Research
View more
  • InvestorPlace

    7 Biotech Stocks That Could Be the Next Big Thing

    While the concept of high-risk speculation seems particularly dangerous at this juncture, gamblers may nevertheless want to consider the merits of targeting potentially lucrative biotech stocks that could be the next big thing. These lesser-known enterprises may not command worldwide attention at the moment. Nevertheless, they could yield tremendous profitability if they come through. Another factor that benefits high-risk, high-reward biotech stocks centers on the underlying sector’s permanent

  • Simply Wall St.

    We're Hopeful That Agios Pharmaceuticals (NASDAQ:AGIO) Will Use Its Cash Wisely

    There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although

  • TipRanks

    TipRanks ‘Perfect 10’ List: These 2 Healthcare Stocks Look Compelling at Current Levels

    With two full months of 2023 behind us, it’s hard to say just how this year is going to shape up. January saw a strong rally, while February was volatile and market analysts and economists are still debating where the long-term trends will head. But what can the retail investor do, while the professionals are debating? A turn to the data may yield some answers – and give clues toward compelling stocks. The Smart Score data tool from TipRanks is specially designed to cut through the fog of uncert